ID   M 144
AC   CVCL_J759
SY   M144; M-10
DR   CLO; CLO_0007439
DR   Wikidata; Q54903373
RX   Patent=US4806628;
RX   Patent=US4808704;
RX   PubMed=7175440;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8440.
CC   Monoclonal antibody isotype: IgG1.
CC   Monoclonal antibody target: Human melanocytes cell surface antigen M-26.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2155 ! P3/NS1/1-Ag4.1
CA   Hybridoma
DT   Created: 11-02-13; Last updated: 21-03-23; Version: 8
//
RX   Patent=US4806628;
RA   Albino A.P., Cairncross J.G., Eisinger M., Houghton A.N., Old L.J.;
RT   "Monoclonal antibodies against melanocytes.";
RL   Patent number US4806628, 21-Feb-1989.
//
RX   Patent=US4808704;
RA   Old L.J., Oettgen H.F., Ikeda H., Li L.T.C., Lloyd K.O., Dippold W.G.;
RT   "Monoclonal antibodies to cell surface antigens of human malignant
RT   melanoma.";
RL   Patent number US4808704, 28-Feb-1989.
//
RX   PubMed=7175440; DOI=10.1084/jem.156.6.1755;
RA   Houghton A.N., Eisinger M., Albino A.P., Cairncross J.G., Old L.J.;
RT   "Surface antigens of melanocytes and melanomas. Markers of melanocyte
RT   differentiation and melanoma subsets.";
RL   J. Exp. Med. 156:1755-1766(1982).
//